P2-purinoceptor Antagonists Discriminate Three Contraction-mediating Receptors for ATP in Rat Vas Deferens
Overview
Authors
Affiliations
The sites of action at which ATP elicits contraction of the rat vas deferens were studied by means of the P2-purinoceptor antagonists pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (iso-PPADS), suramin and reactive blue 2. Increasing concentrations of iso-PPADS (up to 1 mM), suramin (up to 1 mM) and reactive blue 2 (up to 320 microM) reduced and eventually abolished contractions elicited by the P2x-purinoceptor-selective agonist alpha,beta-methylene ATP 3 microM with IC50 values of 2.1, 10.1 and 27.0 microM, respectively. In contrast, iso-PPADS and suramin caused only a partial inhibition of contractions elicited by ATP 1 mM, maximal reduction by about 40%, IC50 values 1.3 and 5.0 microM, respectively; reactive blue 2 did not change ATP-induced contractions. In tissues exposed to iso-PPADS 320 microM throughout, increasing concentrations of reactive blue 2 or suramin decreased contractions elicited by ATP 1 mM, IC50 values 2.6 and 14.5 microM, respectively. In tissues exposed to suramin 320 microM throughout, increasing concentrations of iso-PPADS decreased contractions elicited by ATP 1 mM, IC50 37.9 microM, whereas reactive blue 2 slightly enhanced these contractions. In tissues exposed to reactive blue 2 100 microM throughout, increasing concentrations of iso-PPADS reduced contractions elicited by ATP 1 mM, IC50 26.6 microM, whereas suramin caused no change. Pre-exposure to alpha,beta-methylene ATP 1 microM to desensitize P2x-purinoceptors reduced the response to ATP 1 mM by 91% in otherwise untreated tissues, but did not reduce the response to ATP 1 mM in tissues exposed throughout to iso-PPADS 320 microM, suramin 320 microM or reactive blue 2 100 microM.(ABSTRACT TRUNCATED AT 250 WORDS)
New insights on P2X purinoceptors.
Humphrey P, Buell G, Kennedy I, Khakh B, Michel A, Surprenant A Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(6):585-96.
PMID: 9053729 DOI: 10.1007/BF00171316.
Bultmann R, Dudeck O, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(4):445-51.
PMID: 8935712 DOI: 10.1007/BF00261442.
Bultmann R, Wittenburg H, Pause B, KURZ G, Nickel P, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(4):498-504.
PMID: 8897454 DOI: 10.1007/BF00168442.
Wittenburg H, Bultmann R, Pause B, Ganter C, KURZ G, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(4):491-7.
PMID: 8897453 DOI: 10.1007/BF00168441.
Bultmann R, Pause B, Wittenburg H, KURZ G, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(4):481-90.
PMID: 8897452 DOI: 10.1007/BF00168440.